NRG-BR008/HERO研究：一项针对低风险HER2阳性乳腺癌放疗优化的III期随机试验。
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.
作者信息
Braunstein Lior Z, Mitchell Melissa P, Bandos Hanna, Sikov William M, Khan Atif J, Chen Peter Y, Ganz Patricia A, Jagsi Reshma, White Julia R, Cecchini Reena S, Kang Hyejoo, Puhalla Shannon L, Bolton Kelly L, Connolly Eileen P, Stringer-Reasor Erica M, Gergelis Kimberly R, Julian Thomas B, Mamounas Eleftherios P, Wolmark Norman
机构信息
Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Future Oncol. 2025 Jul;21(16):2017-2025. doi: 10.1080/14796694.2025.2511586. Epub 2025 Jun 26.
Abstract
NCT05705401 (ClinicalTrials.gov).
摘要
NCT05705401（临床试验.gov）。
Zotero 插件